The Molecular Cardiology Unit is engaged in the analysis of intracellular signaling pathways and gene expression regulatory mechanisms with the main focus on angiotensin II. In the process of research, important molecules involved in the pathogenesis of vascular disease will be identified, aiming to develop novel therapies targeting these molecules. Currently three research projects are in progress.